Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $31.4700 (0.77%) ($31.4700 - $31.4700) on Thu. Oct. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.38% (three month average) | RSI | 52 | Latest Price | $31.4700(0.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.2% a day on average for past five trading days. | Weekly Trend | TGTX declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(69%) ARKG(65%) ARKK(61%) IBB(61%) IWO(60%) | Factors Impacting TGTX price | TGTX will decline at least -2.19% in a week (0% probabilities). VIXM(-48%) VXX(-39%) UUP(-19%) UNG(-6%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.19% (StdDev 4.38%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $26.92(-14.46%) | Resistance Level | $32.14 | 5 Day Moving Average | $31.57(-0.32%) | 10 Day Moving Average | $31.93(-1.44%) | 20 Day Moving Average | $32.14(-2.08%) | To recent high | -14.2% | To recent low | 45.2% | Market Cap | $3.986b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |